Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Liabilities and Shareholders Equity (2016 - 2017)

Historic Liabilities and Shareholders Equity for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $1.7 million.

  • Bone Biologics' Liabilities and Shareholders Equity rose 11630.39% to $1.7 million in Q3 2017 from the same period last year, while for Dec 2017 it was $4.2 million, marking a year-over-year decrease of 4792.01%. This contributed to the annual value of $701140.0 for FY2016, which is N/A changed from last year.
  • Latest data reveals that Bone Biologics reported Liabilities and Shareholders Equity of $1.7 million as of Q3 2017, which was up 11630.39% from $868389.0 recorded in Q2 2017.
  • In the past 5 years, Bone Biologics' Liabilities and Shareholders Equity ranged from a high of $4.3 million in Q1 2016 and a low of $701140.0 during Q4 2016